The University of Virginia Board of Visitors voted Friday to extend Dr. K. Craig Kent’s contract as executive vice president for health affairs and chief executive officer for UVA Health through Jan. 31, 2030.
“I am excited to be able to lead UVA Health as we continue to implement our 10-year strategic plan to make UVA Health the nation’s leading public academic health system and best place to work,” Kent said. “We have achieved so much, yet there is still much to accomplish in pursuit of our mission to transform health and inspire hope for all Virginians and beyond. The future is extremely bright.”
As CEO, Kent is responsible for administering all UVA Health operations. Since joining UVA in February 2020, he has overseen substantial expansion, including purchasing and fully integrating three hospitals in Northern Virginia, including dozens of multi-specialty clinics and a physician organization. In July, UVA Health acquired a minority interest in Riverside Health System in Eastern Virginia.
In partnership with UVA President Jim Ryan, Kent helped establish the Paul and Diane Manning Institute of Biotechnology, which had its groundbreaking on Friday.
Under Kent’s leadership, all four UVA Health medical centers earned “A” Hospital Safety Grades for fall 2023 from The Leapfrog Group, a national nonprofit that rates hospitals on how well they provide high-quality patient care. Kent and his team have also maintained financial stability despite the pandemic, staffing shortages and inflation, while many hospital systems throughout the country suffered substantial financial losses.
“My wife Marjie and I look forward to continuing to be part of the wonderful Charlottesville community and all it has to offer,” Kent said.
Media Contact
Article Information
May 4, 2024
